Clear Current Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Boston Bioprocessbostonbioprocess.cominJul 2024
Champaign, US
Michael Tai(Executive Officer, Director)Ted Netland(Executive Officer, Director)
BoardJames Caffyn(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.